Vaccini Covid, the Italian drug agency has banned the use of a batch of doses of Astrazeneca. The decision was made following the reporting of some serious adverse events. Events that occurred in temporal concomitance with the administration of doses of the lot ABV2856 of the Astrazeneca vaccine. Consequently theItalian drug agency (Aifa) has decided as a precaution to issue a ban on the use of this lot throughout the national territory.
Aifa reserves the right to take further measures, where necessary, also in close coordination with EMA, the European pharmaceutical agency. At present there does not appear to be any causal link between the administration of the vaccine and these events. Aifa “is carrying out all the necessary checks, acquiring clinical documentation in close collaboration with i Nas and the relevant authorities. The samples of this lot will be analyzed by the Higher Institute of Health ". The Agency of the drug will promptly communicate "any new information should become available".
Covid vaccines, a batch of Astrazeneca banned
Aifa's decision “follows the news of serious casi of blood clots in people vaccinated with Astrazeneca's Covid-19 vaccine". This is what the Danish Health Authority put it in a statement. The note also adds that "at the moment it has not been determined that there is a link between the vaccine and blood clots". "We will follow the indications and the opinion of the EMA, which is closely monitoring the use of vaccines in the various countries".
So a spokesperson for the European Commission answered questions about the suspension of the Anglo-Swedish vaccine administration in Denmark. “One of the advantages of centralized authorization at the EU level - the spokesman recalled - is monitoring. Consequently, we will follow the indications of the EMA. In making the decision, the Danish authorities were keen to emphasize that this is not an exclusion of the vaccine from the campaign. But, rather, of a "suspension" due to "severe case reports of blood clots in people vaccinated with the medicine AstraZeneca ”.
